Has Bobby Oommen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,088 in general payments to Bobby Oommen, MD across 202 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bobby Oommen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bobby Oommen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bobby Oommen, MD

Physical Medicine & Rehabilitation · Cooperstown, NYNPI 1750532958

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,324 of the $8,088 with a category attached, or 65.8%. 26 manufacturers reported payments, led by Relievant Medsystems, Inc. at 24.1% of the total. Reporting peaked in 2023 at $2,358 and has fallen 74.0% since, to $614 in 2025. Among physical medicine & rehabilitation clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,088in general payments, 2019–2025

Across 202 payments — averaging $40.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Relievant Medsystems, Inc.$2K
Boston Scientific$2K
Medtronic$1K
Abbott$532
SPR Therapeutics, Inc$389
MML US, Inc.$358
plus $2K from 20 others

What the payments were for

Travel & lodging$2,76434%
Food & beverage$5,32466%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Relievant Medsystems, Inc.	13	$1,947
Boston Scientific	40	$1,702
Medtronic(2 entities)	14	$1,372
Abbott	12	$532
SPR Therapeutics, Inc	5	$389
MML US, Inc.	11	$358
Collegium Pharmaceutical, Inc.	18	$328
AbbVie(2 entities)	23	$258
Pfizer	18	$200
Saluda Medical Americas, Inc.	3	$194
Scilex Pharmaceuticals Inc.	16	$150
Amgen(2 entities)	4	$100
Curonix LLC	1	$91
Stryker	1	$81
Nevro Corp.	3	$69
Novartis	4	$56
Vertos Medical, Inc.	2	$48
Biodelivery Sciences International, Inc.	3	$37
Biohaven Pharmaceuticals, Inc.	2	$35
Lilly USA, LLC	2	$31
Baxter Healthcare	1	$29
GRT US Holding, Inc.	1	$21
Fidia Pharma USA Inc.	2	$20
Johnson & Johnson	1	$14
Nalu Medical, Inc.	1	$14
Teva Pharmaceuticals USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,088 in reported general payments places this provider in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York →

Medicare billing

Part B allowed, 2024

$72,277

Medicare patients

221

Services billed

874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mupirocin	17	$149
Methylprednisolone	16	$126
Gabapentin	16	$114
Tizanidine Hcl	22	$87
Meloxicam	17	$21

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Cooperstown

Heidi FuscoNew York$153K
Geraldine DapulRochester$77K
Michael OdellNew York$67K
Craig AntellNew York$65K
Michael StubblefieldNew York$53K
Heakyung KimNew York$53K
Jeffrey BazarianRochester$47K
Martin SchaefferLiverpool$41K
Michael CicchettiWilliamsville$36K
Russell SilverNew York$34K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →